Significant Change to DEA Registration Renewal Process Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. The AMA has strongly expressed our concerns to DEA about this change in policy and the problems it could create for both patients and their physicians. December 14, 2016 AMA American Medical Association, AMA, DEA, Drug Enforcement Administration 0 0 Comment Read More »
REMINDER: Deadline to register for CURES is July 1, 2016 Under California law, all individuals practicing in California who possess both a state regulatory board license authorized to prescribe, dispense, furnish or order controlled substances and a Drug Enforcement Administration Controlled Substance Registration Certificate (DEA Certificate) must submit an application to register for the Controlled Substance Utilization Review and Evaluation System (CURES) by July 1, 2016. June 7, 2016 CMA, News, Physician Resource CMA, CURES, DEA, DOJ 0 0 Comment Read More »
Hydrocodone Products Reclassified to Schedule II DEA has published new rules to reclassify hundreds of medicines containing hydrocodone to Schedule II substances. September 8, 2014 News, Physician Resource controlled substance, DEA, hydrocodone, Schedule II 0 0 Comment Read More »
DEA Controls Tramadol as a Schedule IV Controlled Substance Effective August 18, 2014, tramadol will be classified as a Schedule IV drug, according to a rule recently published by the U.S. Drug Enforcement Agency (DEA). The final rule imposes the regulatory controls and administrative, civil and criminal sanctions applicable to schedule IV controlled substances on persons who handle or propose to handle tramadol. July 9, 2014 News, Physician Resource DEA, Controlled Substances, Schedule IV, tramadol 0 0 Comment Read More »
